Breaking News
Investing Pro 0
NEW! Get Actionable Insights with InvestingPro+ Try 7 Days Free

CVS, Walmart and Walgreens ordered to pay $650.6 million to Ohio counties in opioid case

Stock Markets Aug 17, 2022 02:46PM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items
 
© Reuters. FILE PHOTO: Tablets of the opioid-based Hydrocodone at a pharmacy in Portsmouth, Ohio, June 21, 2017. REUTERS/Bryan Woolston
 
TEVA
+0.65%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
WMT
-0.27%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
JNJ
-0.46%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
ABBV
+0.36%
Add to/Remove from Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 

By Brendan Pierson and Dietrich Knauth

(Reuters) -Pharmacy operators CVS, Walmart (NYSE:WMT) and Walgreens must pay a combined $650.6 million to two Ohio counties to address the damage done by the opioid epidemic, a federal judge ruled Wednesday.

The order by U.S. District Judge Dan Polster in Cleveland marks the first time pharmacy chains have been ordered to pay money in an opioid lawsuit. It comes after a jury last November concluded that the companies helped create a public nuisance in Lake and Trumbull counties by over-supplying addictive pain pills, many of which found their way onto the black market.

"The news today means that we will soon have the long-awaited resources necessary to extend aid to properly address the harms caused by this devastating epidemic," Trumbull County Commissioner Frank Fuda said in a statement.

The pharmacies, which have argued they cannot be liable for filling legal prescriptions from doctors, have said they would appeal that verdict.

Representatives of Walgreens and CVS both said Wednesday's decision was not supported by the law and that they planned to appeal it. Walmart did not immediately respond to a request for comment.

Walgreens was also found liable last week in an opioid lawsuit brought by San Francisco, though the judge has not yet determined how much it must pay there.

Polster said the sum must be paid over 15 years, with the amount for the first two years, or $86.7 million, to be paid immediately. He also ordered the companies to implement new procedures to combat illegal diversion of opioids.

The U.S. opioid epidemic has caused more than 500,000 overdose deaths over two decades, according to government data. More than 3,300 lawsuits have been filed, mostly by local governments, accusing drugmakers, distributors and pharmacy chains of fueling the crisis.

The litigation has resulted in several nationwide settlements, including a $26 billion deal with Johnson & Johnson (NYSE:JNJ) and the three leading distributors, a $2.37 billion settlement with AbbVie Inc (NYSE:ABBV) and a $4.25 billion settlement with Teva Pharmaceutical Industries (NYSE:TEVA) Ltd.

Pharmacies have yet to reach any nationwide settlement, but Walgreens and CVS settled with Florida for $683 million and $484 million, respectively.

CVS, Walmart and Walgreens ordered to pay $650.6 million to Ohio counties in opioid case
 

Related Articles

3 Rumors Flying Around Wall Street Today
3 Rumors Flying Around Wall Street Today By Investing.com - Sep 27, 2022

By Investing.com Staff The Dow and S&P 500 failed to hold gains today, while the Nasdaq eked out a small positive move. However, that didn't stop multiple rumors from flying around...

Today's 3 Most Important Analyst Ratings Initiations
Today's 3 Most Important Analyst Ratings Initiations By Investing.com - Sep 27, 2022

By Davit Kirakosyan Cantor Fitzgerald initiated coverage on Lucid Group Inc (NASDAQ:LCID) with an Overweight rating and a price target of $23.00, noting it believes the company’s...

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Write your thoughts here
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Comments (1)
Stephen Fa
Stephen Fa Sep 19, 2022 8:51AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ridiculous liability for what the FDA allowed and would not stop after so much clarity of death for so many years.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email